Clinical trial
Safety of Reduced Methotrexate Lab Monitoring: a Population-based, Target Trial Emulation Study
NCT07512401 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Reduced Methotrexate Lab Monitoring: a Population-based, Target Trial Emulation Study
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2012
- Completion date
- December 31, 2025
- Enrollment
- 2,414 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.